Perk Labs Inc. (PKLBF)

CTI BioPharma Revenue

Perk Labs had revenue of 9.94K CAD in the quarter ending August 31, 2023, with 83.91% growth. This brings the company's revenue in the last twelve months to 63.16K, up 138.80% year-over-year. In the fiscal year ending November 30, 2022, Perk Labs had annual revenue of 31.59K with 9.12% growth.

• Revenue (ttm): 63.16K CAD
• Revenue Growth: +138.80%
• P/S Ratio: 78.78
• Revenue / Employee: 7.02K CAD
• Employees: 9
• Market Cap: 3.68M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2022	31.59K	2.64K	9.12%
Nov 30, 2021	28.95K	-34.95K	-54.70%
Nov 30, 2020	63.90K	31.80K	99.10%
Nov 30, 2019	32.09K	-2.01M	-98.43%
Nov 30, 2018	2.04M	973.58K	90.95%